Financial Architects (New Jersey)’s ARK Genomic Revolution ETF ARKG Stock Holding History

Financial Architects (New Jersey)’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,635	Closed	-$432K	–	329
2020 Q4	$432K	Buy	+4,635	New	+$369K	0.08%	181
2020 Q3	–	Sell	-1,149	Closed	-$60K	–	303
2020 Q2	$60K	Buy	+1,149	New	+$49.3K	0.01%	391
2019 Q1	–	Sell	-500	Closed	-$12K	–	1418
2018 Q4	$12K	Sell	500 -500	-50%	-$14.1K	﹤0.01%	948
2018 Q3	$33K	Hold	1,000	–	–	0.01%	769
2018 Q2	$29K	Hold	1,000	–	–	0.01%	709
2018 Q1	$26K	Buy	+1,000	New	+$27.1K	0.01%	811

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SDH

Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Financial Architects (New Jersey)'s ARKG Position: Q1 2021 in Review

Financial Architects (New Jersey) sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2021, closing a stake of 4,635 shares — an estimated $432K sold.

Financial Architects (New Jersey) first reported a position in ARKG in Q1 2018 and held it in 6 quarters. The position peaked at $432K in Q4 2020. 505 funds tracked by Wall St. Rank hold ARKG as of Q1 2021.

Financial Architects (New Jersey) reported no remaining ARK Genomic Revolution ETF position as of Q1 2021 after selling out during the quarter.
Financial Architects (New Jersey) sold 4,635 ARK Genomic Revolution ETF shares in Q1 2021, an estimated $432K.
Financial Architects (New Jersey) first reported a position in ARK Genomic Revolution ETF in Q1 2018 and held it in 6 quarters.
Financial Architects (New Jersey)'s ARK Genomic Revolution ETF position peaked at $432K in Q4 2020.
505 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2021.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2021, filed 17 May 2021.